Join to View Full Profile
1800 Orleans St.,Sheikh Zayed TowerBaltimore, MD 21287
Phone+1 443-923-9525
Fax+1 443-923-9405
Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1995
- Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
MD State Medical License 1998 - 2025
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Start of enrollment: 2010 Sep 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
- Join now to see all
Publications & Presentations
PubMed
- Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophy.Leo H Wang, Maya N Hatch, Michael P McDermott, William B Martens, Katy Eichinger
Neuromuscular Disorders. 2025-03-01 - 5 citationsSafety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland
The Lancet. Neurology. 2024-05-01 - 6 citationsThe Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.Francesco Muntoni, Barry J Byrne, Hugh J McMillan, Monique M Ryan, Brenda L Wong
Neurology and Therapy. 2024-02-01
Press Mentions
- Longitudinal Functional and Imaging Outcome Measures in FKRP Limb-Girdle Muscular DystrophyMay 19th, 2020
Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual ConferenceJune 27th, 2019
Professional Memberships
- Member
External Links
- Wagner labhttps://www.thewagnerlab.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
